Snapshot

The FDA Accelerated Approval pathway has been developed by the US Food and Drug Administration of United States.

This pathway can be used where drugs and biologics.

This pathway accelerates the regulatory review process.

It is an abridged review (a reliance pathway).

Target time assessment is Info not found.